Flexion Therapeutics — Q2 2020 Earnings Presentation
7 slides from Flexion Therapeutics's earnings presentation, Jul 14, 2020
Slide 1: Commercial Metrics Overview
Commercial Metrics Overview July 14,2020 Exhibit 99.2
Slide 2: Commercial Metrics Overview
Commercial Metrics Overview ZILRETTA® net sales of ~$15.4 million in Q2 2020 3,858 accounts (of 5,000 targets) have purchased ZILRETTA, as of June 30, 2020; up from 3,672, as of March 31, 2020 2,983 accounts have re-ordered ZILRETTA (77% of accounts that had purchased), as of June 30, 2020; up from
Slide 3: ZILRETTA Net Sales Quarterly Since Launch
ZILRETTA Net Sales Quarterly Since Launch Note: Flexion recognizes Zilretta sales upon receipt of product by specialty distributors and pharmacies.
Slide 4: Accounts by ZILRETTA Purchases Cumulative
Distribution of Accounts by ZILRETTA Purchases Cumulative Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics and certain medical centers or hospitals) then subsequently purchase ZILRETTA directly from these specialty distributors
Slide 5: ZILRETTA Purchases by Accounts Cumulative
Distribution of ZILRETTA Purchases by Accounts Cumulative Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics and certain medical centers or hospitals) then subsequently purchase ZILRETTA directly from these specialty distributors
Slide 6: ZILRETTA Purchases by New and Existing Accounts Cumulative
Distribution of ZILRETTA Purchases by New and Existing Accounts Cumulative Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics and certain medical centers or hospitals) then subsequently purchase ZILRETTA directly from these specia
Slide 7: Flexion: Transformative Medicine... Where It Matters
clevion Transformative Medicine... Where It Matters